Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
Retatrutide is an experimental weekly weight management injection developed by Eli Lilly, currently undergoing clinical trials for the treatment of obesity, type 2 diabetes, and potentially other metabolic conditions
You can eat less, you absorb fewer calories, and your hunger hormones decrease, reducing your appetite and making you feel fuller
If you want systemic effects plus local hair benefit, some protocols combine daily subcutaneous injection with scalp topical
The 2.5mg starting dose is the initiation dose used in all SURMOUNT trials
Lyophilised Bacteriostatic Water is stable at -20C long-term
NAD+ treatments not only help with the cosmetic side of ageing and cell rejuvenation, they can also help reduce the risks of age related diseases
